Leila Alland

CIK: 0001825216

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CRDF

Cardiff Oncology, Inc.

Officer

ABEO

ABEONA THERAPEUTICS INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

ABEO
ABEONA THERAPEUTICS INC.
Jun 30, 2026
Sale(S)
Direct
11K shares at avg. $5.92$65K
ABEO
ABEONA THERAPEUTICS INC.
Feb 2, 2026
Sale(S)
Direct
18.1K shares at avg. $5.09$92K
ABEO
ABEONA THERAPEUTICS INC.
Jan 26, 2026
Award(A)
Direct
37.3K shares-
ABEO
ABEONA THERAPEUTICS INC.
Jan 31, 2025
Award(A)
Direct
36.1K shares-

		Type	Shares	Price		Ownership
Jun 30, 2026	ABEO ABEONA THERAPEUTICS INC.	Sale(S)	11,000	$5.92	$65,087	Direct
Feb 2, 2026	ABEO ABEONA THERAPEUTICS INC.	Sale(S)	18,065	$5.09	$91,962	Direct
Jan 26, 2026	ABEO ABEONA THERAPEUTICS INC.	Award(A)	37,313	-	$0	Direct
Jan 31, 2025	ABEO ABEONA THERAPEUTICS INC.	Award(A)	36,101	-	-	Direct

1-4 of 4 transactions

About Alland Leila

Alland Leila (SEC CIK 0001825216) files insider reports with the SEC as Chief Medical Officer of Cardiff Oncology, Inc. (CRDF) and Director of ABEONA THERAPEUTICS INC. (ABEO).

Signal8 holds 5 ownership filings by Alland Leila (1 Form 3, 4 Form 4), filed between Feb 3, 2025 and Oct 27, 2026. Those filings report 4 transactions, from Jan 31, 2025 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Alland Leila's filings is in SAN DIEGO, CA.

Recent filings by Alland Leila

Jun 30, 2026: Open-market sale of ABEO shares (Form 4, code S).
Feb 2, 2026: Open-market sale of ABEO shares (Form 4, code S).
Jan 26, 2026: Grant or award of ABEO shares (Form 4, code A).
Jan 31, 2025: Grant or award of ABEO shares (Form 4, code A).

Other insiders filing for Cardiff Oncology, Inc. (CRDF)

PACE GARY W, Director
Mohindru Mani, Chief Executive Officer
Armitage James O, Director
White Lale, Director
TANNENBAUM RENEE P, Director
Markin Rodney S, Director

How to read Form 4 transaction codes